A Phase II Dose Response Study in Japan in Chronic Hepatitis B

NCT01022801 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
120
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Bristol-Myers Squibb